MPS III Sanfilippo Syndrome Whole Blood

<h2>MPS III (Sanfilippo Syndrome) Whole Blood for Research</h2>
Sanfilippo syndrome (MPS III) is a rare lysosomal storage disorder caused by enzyme deficiencies that lead to heparan sulfate accumulation and progressive pediatric neurodegeneration. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed MPS III diagnosis for rare disease and genomic research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed MPS III donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed MPS III diagnosis, including enzyme/genetic testing results where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and developmental history</li></ul>
<h3>Applications</h3>
<ul><li>Heparan sulfate and glycosaminoglycan biomarker studies</li><li>Lysosomal enzyme and genetic research</li><li>Gene expression and transcriptomic analysis</li><li>Enzyme replacement and gene therapy research</li></ul>
<h3>Also Available</h3>
MPS III samples are also available as PBMC and serum – contact us to discuss the right specimen type for your study.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
MPS III whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.